PharmaTimes: News RSS
- Monte Rosa Therapeutics raises $96m to develop protein-degrading molecules
- UK consumers seeking advice from pharmacists during pandemic, research finds
- Novavax begins phase III coronavirus vaccine trial in the UK
- Accord Healthcare launches Herceptin biosimilar in the UK
- Oncimmune partners with Genentech to profile samples from rheumatology trials
- Verona Pharma launches late-stage COPD trial programme
- FDA and EMA accept regulatory submissions for UCB’s bimekizumab
- NHS COVID-19 app launches in England and Wales
- Digital tech has health benefits for dementia patients, project finds
- Owlstone Medical’s breath biopsy test improves detection of liver disease
English
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish
Leave a Reply
Want to join the discussion?Feel free to contribute!